Discover trends, market shifts, and competitive outlooks for the gastric volvulus treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Gastric Volvulus Treatment Market Size from 2025 to 2034?

In recent times, the market size for gastric volvulus treatment has seen a vigorous expansion. The market is projected to expand from $27.36 billion in 2024 to $28.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. This growth during the historic period can be ascribed to the progression in surgical procedures, enhancements in diagnostic technologies, raised awareness and education, the surge in minimally invasive procedures, as well as research and clinical trials.

Expectations are high for a robust expansion in the market size for gastric volvulus treatment in the following years. The market is forecasted to elevate to $37.48 billion in 2029 with a compound annual growth rate (CAGR) of 6.7%. The accelerative growth predicted within this period can be accredited to adjustments in regulation, endorsements, surgical procedure innovations, a growing elderly population, personalized treatment schemes, and the adoption of advanced imaging methods. The forecast period will also see major trends like the adoption of minimally invasive surgical procedures, early intervention, and heightened awareness, advancements in treatment research, cooperative medical practices, and personal treatment strategies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gastric Volvulus Treatment Market?

The anticipated increase in the population of elderly adults, those aged 65 and above, is predicted to stimulate significant expansions in the gastric volvulus treatment market in the future. This age demographic is susceptible to various illnesses due to age-related declines in immunity. Gastric volvulus is one such condition predominantly affecting individuals over 50 years old. Therefore, an expansion in the geriatric population is a key factor expected to fuel the market. Moreover, data from the Population Reference Bureau (PRB), a not-for-profit body based in the U.S., disclosed in January 2024 that the segment of Americans who are 65 years and older will surge from 58 million in 2022 to 82 million in 2050, a boost of 47%. Additionally, their share of the total population will also rise from 17% to 23%. Thus, escalations in the geriatric populations stand as a strong propellant for the growth of the gastric volvulus treatment market.

Which Key Market Segments Comprise the Gastric Volvulus Treatment Market and Drive Its Revenue Growth?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Which Areas Are Leading Regions in the Gastric Volvulus Treatment Market Expansion Across the Globe?

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in the Gastric Volvulus Treatment Market Over the Coming Years?

In the gastric volvulus treatment market, product innovation is emerging as a crucial trend. To maintain their significance in the market, leading corporations are launching state-of-the-art products. Pfizer Inc., an American pharmaceutical firm, exemplified this in October 2023 when it revealed that the U.S. Food and Drug Administration (FDA) had sanctioned VELSIPITY (etrasimod). This medication, which is an oral sphingosine-1-phosphate (S1P) receptor activator, is administrated once daily for patients with moderate to severe active ulcerative colitis (UC). The recommended dosage of VELSIPITY is 2 mg. This drug enables adults with UCS to accomplish steroid-free resolution utilizing a daily oral pill that strikes a balance between benefits and risks. The FDA’s approval of VELSIPITY indicates a significant milestone for UC patients needing new treatment alternatives for their chronic condition and are prepared to commence advanced therapy.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

How Is the Gastric Volvulus Treatment Market Conceptually Defined?

Gastric volvulus treatment refers to surgical treatment, specifically volvulus reduction, reintegration of the stomach into the abdominal cavity in cases of intrathoracic migration, and correction of causal factors. Gastric volvulus surgery is usually simple, involving de-rotation, lowering of the hernial contents into the abdominal wall, and repair of the hernial defect.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model